Semaglutide for weight loss: Wegovy, Ozempic and the difference

Ozempic® is not FDA-approved for weight loss. It is approved for blood sugar control in adults with type 2 diabetes. If weight loss is your goal, the FDA-approved semaglutide option is Wegovy®.

Ozempic is a form of semaglutide given once a week through an injection pen. Doctors first used it to help people with type 2 diabetes regulate blood sugar. Wegovy contains the same active ingredient and is the product approved for chronic weight management. A clear understanding of the difference between the two can help you speak with your clinician confidently.

What Semaglutide Does

Semaglutide mimics a hormone that signals fullness and slows digestion. In trials of the FDA-approved products, this produced weight loss alongside a reduced-calorie diet and increased activity. Compounded formulations have not been studied in clinical trials, and the FDA does not evaluate them for safety, effectiveness, or quality.

Who May Qualify

Doctors consider a few basic points:

Body mass index above the medical threshold for weight loss treatment
A history of weight gain despite reasonable diet and activity efforts
A need to prevent complications related to excess weight

Some clinics may ask about previous attempts with other treatments. A prescription is never guaranteed and is at the treating provider’s sole discretion.

What a Consultation Usually Involves

A medical visit.The clinician reviews your medical history, current conditions, and any medicines you already use.
Standard lab tests.These might include blood sugar levels, cholesterol, or liver function.
A discussion of dose and expectations.Treatment begins at a low dose, which rises only if you tolerate it well.
Follow-up appointments.These visits let the clinician track weight, side effects, and progress.

Safety and Monitoring

Your doctor will monitor symptoms such as nausea, changes in appetite, or any unusual discomfort. Reporting these early helps them adjust your dose safely.